| myeloid cell differentiation | GO:0030099 | 233 | 0.465 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.293 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.272 | |
| spermatogenesis | GO:0007283 | 284 | 0.257 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.256 | |
| protein catabolic process | GO:0030163 | 221 | 0.221 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.171 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.169 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.157 | |
| glial cell apoptotic process | GO:0034349 | 3 | 0.149 | |
| neural tube development | GO:0021915 | 160 | 0.147 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.142 | |
| dna metabolic process | GO:0006259 | 303 | 0.139 | |
| chromatin modification | GO:0016568 | 187 | 0.138 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.134 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.133 | |
| rhythmic process | GO:0048511 | 174 | 0.132 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.131 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.131 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.129 | |
| male gamete generation | GO:0048232 | 285 | 0.125 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.117 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.116 | |
| amine metabolic process | GO:0009308 | 45 | 0.107 | |
| histone h4 k16 acetylation | GO:0043984 | 3 | 0.106 | |
| germ cell development | GO:0007281 | 185 | 0.100 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.095 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.094 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.094 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.094 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.087 | Fly |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.087 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.086 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.083 | |
| axonogenesis | GO:0007409 | 274 | 0.082 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.080 | Fly |
| covalent chromatin modification | GO:0016569 | 163 | 0.079 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.079 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.076 | |
| membrane organization | GO:0061024 | 245 | 0.074 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.074 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.073 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.072 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.072 | |
| epithelial tube formation | GO:0072175 | 130 | 0.072 | |
| organelle assembly | GO:0070925 | 177 | 0.071 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.069 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.069 | |
| histone modification | GO:0016570 | 159 | 0.067 | |
| inflammatory response | GO:0006954 | 244 | 0.067 | |
| spermatid differentiation | GO:0048515 | 115 | 0.067 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.067 | |
| negative regulation of osteoblast proliferation | GO:0033689 | 4 | 0.065 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.065 | |
| neural tube formation | GO:0001841 | 108 | 0.065 | |
| t cell proliferation | GO:0042098 | 120 | 0.065 | |
| release of cytochrome c from mitochondria | GO:0001836 | 23 | 0.065 | |
| response to radiation | GO:0009314 | 165 | 0.064 | |
| mrna processing | GO:0006397 | 63 | 0.063 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.063 | |
| response to light stimulus | GO:0009416 | 135 | 0.062 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.062 | |
| chromatin organization | GO:0006325 | 206 | 0.061 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.061 | |
| tube formation | GO:0035148 | 140 | 0.061 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.060 | |
| digestive tract development | GO:0048565 | 190 | 0.059 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.058 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.056 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.056 | |
| double strand break repair | GO:0006302 | 48 | 0.055 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.054 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.054 | |
| epidermis development | GO:0008544 | 187 | 0.053 | |
| t cell activation | GO:0042110 | 289 | 0.053 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.052 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.052 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.052 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.051 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.051 | |
| mrna metabolic process | GO:0016071 | 84 | 0.051 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.050 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.050 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.050 | |
| multicellular organism growth | GO:0035264 | 161 | 0.050 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 58 | 0.049 | |
| regulation of cell activation | GO:0050865 | 289 | 0.049 | |
| digestive system development | GO:0055123 | 200 | 0.049 | |
| cytokine production | GO:0001816 | 319 | 0.049 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.049 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.049 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.049 | |
| vesicle organization | GO:0016050 | 60 | 0.049 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.048 | |
| response to oxidative stress | GO:0006979 | 123 | 0.047 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.044 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.044 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.044 | |
| negative regulation of cyclin dependent protein serine threonine kinase activity | GO:0045736 | 9 | 0.044 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.044 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.044 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.043 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.043 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 57 | 0.041 | |
| rna processing | GO:0006396 | 105 | 0.041 | |
| response to oxygen levels | GO:0070482 | 62 | 0.041 | |
| mrna catabolic process | GO:0006402 | 22 | 0.041 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.041 | |
| protein ubiquitination | GO:0016567 | 171 | 0.041 | |
| dna templated transcriptional preinitiation complex assembly | GO:0070897 | 4 | 0.041 | |
| neural tube closure | GO:0001843 | 90 | 0.041 | |
| ovulation cycle | GO:0042698 | 59 | 0.040 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.040 | |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 49 | 0.039 | |
| spermatid development | GO:0007286 | 108 | 0.039 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.039 | |
| positive regulation of thymocyte migration | GO:2000412 | 2 | 0.038 | |
| secretory granule organization | GO:0033363 | 20 | 0.038 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.038 | |
| regulation of interleukin 1 alpha production | GO:0032650 | 4 | 0.036 | |
| tumor necrosis factor ligand superfamily member 11 production | GO:0072535 | 1 | 0.036 | |
| regionalization | GO:0003002 | 337 | 0.036 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.036 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.035 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.035 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.035 | |
| positive regulation of interleukin 1 alpha production | GO:0032730 | 4 | 0.035 | |
| signal transduction involved in mitotic dna damage checkpoint | GO:1902402 | 3 | 0.035 | |
| positive regulation of myeloid leukocyte differentiation | GO:0002763 | 26 | 0.034 | |
| signal transduction involved in dna damage checkpoint | GO:0072422 | 3 | 0.034 | |
| cellular response to peptide | GO:1901653 | 92 | 0.034 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.034 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.034 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.034 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.034 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.033 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.033 | |
| definitive hemopoiesis | GO:0060216 | 20 | 0.033 | |
| dna repair | GO:0006281 | 107 | 0.033 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.033 | |
| response to peptide | GO:1901652 | 136 | 0.032 | |
| innate immune response | GO:0045087 | 157 | 0.032 | |
| protein maturation | GO:0051604 | 176 | 0.032 | |
| apoptotic mitochondrial changes | GO:0008637 | 48 | 0.032 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.032 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.032 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.032 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.032 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.031 | |
| negative regulation of dna replication | GO:0008156 | 4 | 0.031 | |
| dna endoreduplication | GO:0042023 | 4 | 0.031 | |
| protein processing | GO:0016485 | 163 | 0.031 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.031 | |
| deoxyribonucleoside triphosphate biosynthetic process | GO:0009202 | 2 | 0.031 | |
| oocyte axis specification | GO:0007309 | 2 | 0.031 | |
| circadian regulation of gene expression | GO:0032922 | 48 | 0.031 | |
| membrane lipid metabolic process | GO:0006643 | 53 | 0.031 | |
| histone methylation | GO:0016571 | 71 | 0.031 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.031 | |
| t cell differentiation | GO:0030217 | 174 | 0.031 | |
| primary neural tube formation | GO:0014020 | 95 | 0.031 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.030 | |
| dna templated transcription termination | GO:0006353 | 4 | 0.030 | |
| positive regulation of growth | GO:0045927 | 104 | 0.030 | |
| sphingolipid metabolic process | GO:0006665 | 45 | 0.030 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.030 | |
| regulation of transcription involved in g1 s transition of mitotic cell cycle | GO:0000083 | 3 | 0.030 | |
| regulation of defense response | GO:0031347 | 233 | 0.030 | |
| compound eye development | GO:0048749 | 1 | 0.030 | Fly |
| regulation of chromatin silencing | GO:0031935 | 2 | 0.029 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.029 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.029 | |
| dna replication | GO:0006260 | 52 | 0.029 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.029 | |
| regulation of apoptotic dna fragmentation | GO:1902510 | 5 | 0.029 | |
| cellular response to topologically incorrect protein | GO:0035967 | 25 | 0.029 | |
| skin development | GO:0043588 | 220 | 0.029 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.029 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.029 | |
| protein methylation | GO:0006479 | 81 | 0.029 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.029 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.029 | |
| endomembrane system organization | GO:0010256 | 147 | 0.029 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.029 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.028 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.028 | |
| protein alkylation | GO:0008213 | 81 | 0.028 | |
| signal transduction involved in dna integrity checkpoint | GO:0072401 | 3 | 0.028 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.028 | |
| regulation of secretion | GO:0051046 | 274 | 0.028 | |
| camera type eye development | GO:0043010 | 266 | 0.028 | |
| positive regulation of defense response to bacterium | GO:1900426 | 1 | 0.028 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.028 | |
| rna polymerase ii transcriptional preinitiation complex assembly | GO:0051123 | 3 | 0.027 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.027 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.027 | |
| circadian rhythm | GO:0007623 | 114 | 0.027 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.027 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.027 | |
| muscle contraction | GO:0006936 | 101 | 0.027 | |
| protein deacetylation | GO:0006476 | 32 | 0.027 | |
| gland development | GO:0048732 | 330 | 0.027 | |
| activation of cysteine type endopeptidase activity | GO:0097202 | 27 | 0.027 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.026 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.026 | |
| blastocyst development | GO:0001824 | 80 | 0.025 | |
| rna catabolic process | GO:0006401 | 29 | 0.025 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.025 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.025 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.025 | |
| forebrain development | GO:0030900 | 302 | 0.025 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.025 | |
| skeletal system development | GO:0001501 | 356 | 0.025 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.025 | |
| protein secretion | GO:0009306 | 111 | 0.024 | |
| dna integrity checkpoint | GO:0031570 | 28 | 0.024 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.024 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.024 | |
| positive regulation of myeloid cell differentiation | GO:0045639 | 43 | 0.024 | |
| tissue remodeling | GO:0048771 | 102 | 0.024 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.024 | |
| gastrulation | GO:0007369 | 116 | 0.024 | |
| angiogenesis | GO:0001525 | 201 | 0.024 | |
| epithelial cell development | GO:0002064 | 159 | 0.024 | |
| stem cell differentiation | GO:0048863 | 268 | 0.024 | |
| urogenital system development | GO:0001655 | 261 | 0.024 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.023 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 39 | 0.023 | |
| neuron projection guidance | GO:0097485 | 141 | 0.023 | |
| regulation of proteasomal protein catabolic process | GO:0061136 | 46 | 0.023 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.023 | |
| respiratory tube development | GO:0030323 | 167 | 0.023 | |
| male sex differentiation | GO:0046661 | 109 | 0.023 | |
| chemotaxis | GO:0006935 | 247 | 0.023 | |
| cell adhesion | GO:0007155 | 329 | 0.023 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.023 | |
| regulation of protein stability | GO:0031647 | 52 | 0.023 | |
| apoptotic nuclear changes | GO:0030262 | 9 | 0.023 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.023 | |
| sensory perception of sound | GO:0007605 | 97 | 0.023 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.023 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.022 | |
| stem cell development | GO:0048864 | 219 | 0.022 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.022 | |
| positive regulation of transcription elongation from rna polymerase ii promoter | GO:0032968 | 2 | 0.022 | |
| protein polyubiquitination | GO:0000209 | 33 | 0.022 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.022 | |
| oocyte construction | GO:0007308 | 2 | 0.022 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.022 | |
| cellular component disassembly involved in execution phase of apoptosis | GO:0006921 | 9 | 0.022 | |
| cell cycle g1 s phase transition | GO:0044843 | 57 | 0.022 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.022 | |
| transcription initiation from rna polymerase ii promoter | GO:0006367 | 8 | 0.021 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.021 | |
| positive regulation of endopeptidase activity | GO:0010950 | 43 | 0.021 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.021 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.021 | |
| regulation of interleukin 1 alpha secretion | GO:0050705 | 3 | 0.021 | |
| developmental maturation | GO:0021700 | 193 | 0.021 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.021 | |
| adult behavior | GO:0030534 | 135 | 0.021 | |
| zymogen activation | GO:0031638 | 41 | 0.021 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.021 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.021 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 36 | 0.021 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.021 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.021 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.021 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.021 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.021 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.020 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.020 | |
| b cell differentiation | GO:0030183 | 78 | 0.020 | |
| response to hypoxia | GO:0001666 | 58 | 0.020 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.020 | |
| prevention of polyspermy | GO:0060468 | 4 | 0.020 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.020 | |
| memory | GO:0007613 | 58 | 0.020 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.020 | |
| transcription from rna polymerase i promoter | GO:0006360 | 13 | 0.020 | |
| cognition | GO:0050890 | 149 | 0.020 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.020 | |
| activation of cysteine type endopeptidase activity involved in apoptotic process | GO:0006919 | 27 | 0.019 | |
| regulation of execution phase of apoptosis | GO:1900117 | 9 | 0.019 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.019 | |
| execution phase of apoptosis | GO:0097194 | 19 | 0.019 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.019 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.019 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.019 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.019 | |
| signal transduction involved in mitotic cell cycle checkpoint | GO:0072413 | 3 | 0.019 | |
| actin filament organization | GO:0007015 | 113 | 0.019 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.019 | |
| male gonad development | GO:0008584 | 88 | 0.019 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.019 | |
| cellular response to lipid | GO:0071396 | 145 | 0.019 | |
| maintenance of location | GO:0051235 | 89 | 0.019 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.019 | |
| response to insulin | GO:0032868 | 100 | 0.019 | |
| cell growth | GO:0016049 | 130 | 0.019 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.019 | |
| methylation | GO:0032259 | 134 | 0.019 | |
| interleukin 1 alpha secretion | GO:0050703 | 3 | 0.019 | |
| microtubule based process | GO:0007017 | 236 | 0.019 | |
| dna damage checkpoint | GO:0000077 | 26 | 0.019 | |
| fertilization | GO:0009566 | 127 | 0.019 | |
| muscle tissue development | GO:0060537 | 308 | 0.019 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.019 | |
| peptidyl lysine trimethylation | GO:0018023 | 12 | 0.018 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.018 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.018 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.018 | |
| regulation of protein transport | GO:0051223 | 163 | 0.018 | |
| response to granulocyte macrophage colony stimulating factor | GO:0097012 | 3 | 0.018 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.018 | |
| signal transduction involved in cell cycle checkpoint | GO:0072395 | 3 | 0.018 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.018 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.018 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.018 | |
| cellular response to gamma radiation | GO:0071480 | 4 | 0.018 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.018 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.018 | |
| response to drug | GO:0042493 | 75 | 0.018 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.018 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.018 | |
| gonad development | GO:0008406 | 141 | 0.018 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.018 | |
| response to endoplasmic reticulum stress | GO:0034976 | 53 | 0.018 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.017 | |
| signal transduction involved in mitotic dna integrity checkpoint | GO:1902403 | 3 | 0.017 | |
| thymocyte apoptotic process | GO:0070242 | 19 | 0.017 | |
| rna splicing via transesterification reactions | GO:0000375 | 43 | 0.017 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.017 | |
| response to peptide hormone | GO:0043434 | 127 | 0.017 | |
| chromatin silencing at rdna | GO:0000183 | 3 | 0.017 | |
| negative regulation of myeloid cell differentiation | GO:0045638 | 38 | 0.017 | |
| mrna splicing via spliceosome | GO:0000398 | 43 | 0.017 | |
| cilium assembly | GO:0042384 | 81 | 0.017 | |
| peptidyl lysine methylation | GO:0018022 | 29 | 0.017 | |
| positive regulation of tor signaling | GO:0032008 | 3 | 0.017 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.017 | |
| regulation of insulin receptor signaling pathway | GO:0046626 | 21 | 0.017 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.017 | |
| stem cell maintenance | GO:0019827 | 130 | 0.017 | |
| b cell activation | GO:0042113 | 161 | 0.017 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.017 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.016 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.016 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.016 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.016 | |
| mitotic g1 dna damage checkpoint | GO:0031571 | 4 | 0.016 | |
| dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest | GO:0006977 | 3 | 0.016 | |
| fat cell differentiation | GO:0045444 | 160 | 0.016 | |
| liposaccharide metabolic process | GO:1903509 | 27 | 0.016 | |
| cilium morphogenesis | GO:0060271 | 102 | 0.016 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.016 | |
| regulation of alpha beta t cell differentiation | GO:0046637 | 35 | 0.016 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.016 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.016 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.016 | |
| female gonad development | GO:0008585 | 71 | 0.016 | |
| positive regulation of synaptic growth at neuromuscular junction | GO:0045887 | 1 | 0.016 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.016 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.016 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.016 | |
| dna templated transcription initiation | GO:0006352 | 13 | 0.016 | |
| hormone secretion | GO:0046879 | 128 | 0.016 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.016 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.015 | |
| synaptic transmission | GO:0007268 | 329 | 0.015 | |
| regulation of mrna processing | GO:0050684 | 41 | 0.015 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.015 | |
| regulation of histone h3 k4 methylation | GO:0051569 | 12 | 0.015 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.015 | |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.015 | |
| lung development | GO:0030324 | 164 | 0.015 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.015 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.015 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.015 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.015 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.015 | |
| regulation of defense response to bacterium | GO:1900424 | 3 | 0.015 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.015 | |
| glial cell differentiation | GO:0010001 | 131 | 0.015 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.015 | |
| positive regulation of nf kappab transcription factor activity | GO:0051092 | 30 | 0.015 | |
| cellularization | GO:0007349 | 1 | 0.015 | |
| protein localization to organelle | GO:0033365 | 185 | 0.015 | |
| sensory perception | GO:0007600 | 245 | 0.015 | |
| regulation of mrna metabolic process | GO:1903311 | 43 | 0.015 | |
| rna splicing | GO:0008380 | 54 | 0.015 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway | GO:2001267 | 4 | 0.015 | |
| extracellular matrix dependent thymocyte migration | GO:0072680 | 1 | 0.015 | |
| regulation of lymphocyte apoptotic process | GO:0070228 | 41 | 0.015 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.015 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.014 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.014 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.014 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.014 | |
| histone deacetylation | GO:0016575 | 26 | 0.014 | |
| viral gene expression | GO:0019080 | 3 | 0.014 | |
| localization within membrane | GO:0051668 | 4 | 0.014 | |
| regulation of nuclear cell cycle dna replication | GO:0033262 | 2 | 0.014 | |
| oogenesis | GO:0048477 | 56 | 0.014 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.014 | |
| regulation of binding | GO:0051098 | 111 | 0.014 | |
| intracellular signal transduction involved in g1 dna damage checkpoint | GO:1902400 | 3 | 0.014 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 49 | 0.014 | |
| negative regulation of protein depolymerization | GO:1901880 | 21 | 0.014 | |
| neuron death | GO:0070997 | 154 | 0.014 | |
| t cell differentiation involved in immune response | GO:0002292 | 30 | 0.014 | |
| muscle system process | GO:0003012 | 141 | 0.014 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.014 | |
| cell fate commitment | GO:0045165 | 210 | 0.014 | Fly |
| t cell apoptotic process | GO:0070231 | 39 | 0.014 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.014 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.014 | |
| regulation of cellular protein catabolic process | GO:1903362 | 61 | 0.014 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.014 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.014 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.014 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.014 | |
| regulation of t cell differentiation | GO:0045580 | 83 | 0.014 | |
| hepatocyte apoptotic process | GO:0097284 | 11 | 0.014 | |
| chromatin remodeling | GO:0006338 | 32 | 0.014 | |
| macromolecule methylation | GO:0043414 | 120 | 0.014 | |
| macrophage differentiation | GO:0030225 | 20 | 0.014 | |
| lens development in camera type eye | GO:0002088 | 62 | 0.014 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.014 | |
| immune effector process | GO:0002252 | 321 | 0.014 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.014 | |
| b cell proliferation | GO:0042100 | 53 | 0.014 | |
| fibronectin dependent thymocyte migration | GO:0072681 | 1 | 0.014 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.014 | |
| developmental cell growth | GO:0048588 | 84 | 0.014 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.013 | |
| glycosylation | GO:0070085 | 62 | 0.013 | |
| regulation of thymocyte apoptotic process | GO:0070243 | 14 | 0.013 | |
| cell division | GO:0051301 | 120 | 0.013 | |
| regulation of protein localization | GO:0032880 | 231 | 0.013 | |
| positive regulation of histone modification | GO:0031058 | 28 | 0.013 | |
| response to topologically incorrect protein | GO:0035966 | 25 | 0.013 | |
| microtubule cytoskeleton organization involved in mitosis | GO:1902850 | 4 | 0.013 | |
| natural killer cell proliferation | GO:0001787 | 3 | 0.013 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.013 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.013 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.013 | |
| mesoderm formation | GO:0001707 | 62 | 0.013 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.013 | |
| negative regulation of b cell activation | GO:0050869 | 27 | 0.013 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.013 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.013 | |
| rna interference | GO:0016246 | 2 | 0.013 | |
| er nucleus signaling pathway | GO:0006984 | 27 | 0.013 | |
| glycolipid metabolic process | GO:0006664 | 25 | 0.013 | |
| protein depolymerization | GO:0051261 | 34 | 0.013 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.013 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.013 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.013 | |
| regulation of cell migration | GO:0030334 | 219 | 0.013 | |
| t cell homeostasis | GO:0043029 | 35 | 0.013 | |
| humoral immune response | GO:0006959 | 57 | 0.013 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.013 | |
| response to steroid hormone | GO:0048545 | 56 | 0.013 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.013 | |
| positive regulation of protein oligomerization | GO:0032461 | 4 | 0.013 | |
| positive regulation of antibacterial peptide biosynthetic process | GO:0006963 | 1 | 0.012 | |
| histone h4 k20 methylation | GO:0034770 | 8 | 0.012 | |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002824 | 61 | 0.012 | |
| cytokine metabolic process | GO:0042107 | 71 | 0.012 | |
| regulation of transcription during meiosis | GO:0051037 | 1 | 0.012 | |
| cell cell recognition | GO:0009988 | 44 | 0.012 | |
| transdifferentiation | GO:0060290 | 1 | 0.012 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.012 | |
| response to monosaccharide | GO:0034284 | 67 | 0.012 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.012 | |
| megakaryocyte differentiation | GO:0030219 | 26 | 0.012 | |
| learning or memory | GO:0007611 | 148 | 0.012 | |
| actin filament polymerization | GO:0030041 | 44 | 0.012 | |
| nucleus organization | GO:0006997 | 45 | 0.012 | |
| female sex differentiation | GO:0046660 | 84 | 0.012 | |
| dna catabolic process endonucleolytic | GO:0000737 | 15 | 0.012 | |
| negative regulation of b cell proliferation | GO:0030889 | 13 | 0.012 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.012 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.012 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.012 | |
| histone h3 k4 trimethylation | GO:0080182 | 5 | 0.012 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.012 | |
